Table 2.

Univariate Analysis of Survival for all Patients

	DFS 20		DFS 36		DFS 60
	pa	HR	pa	HR	pa	HR
Sex
Male	0.39	1.37	0.69	1.12	0.94	0.98
Female		1		1		1
Astler-Coller
B2	0.0027	0.32	0.0065	0.45	0.0004	0.41
C		1		1		1
Grade
1/2	0.50	0.66	0.92	1.07	0.19	0.58
3		1		1		1
Tumor location
Right-side tumor	0.96	0.98	0.34	0.69	0.12	0.59
Left-side tumor		1		1		1
Tumor location
Rectum	0.66	1.17	0.22	1.43	0.0088	1.92
Colon		1		1		1
Chemotherapy
Yes	0.92	1.04	0.65	1.19	0.53	1.23
No		1		1		1
Age
<63	0.36	0.72	0.74	0.91	0.66	1.11
≥63		1		1		1
5′-TSER TS
High TS 3G/3G, 3G/3C, 2R/3G	0.043	2.13	0.17	1.57	0.22	1.42
Low TS 3C/3C, 2R/3C, 2R/2R		1		1		1

^aTest long-rank.

DFS 20, DFS 36, DFS 60, disease-free survival at 20, 36, and 60 months; HR, hazard ratio.